The expansion of newborn screening programs for FAODs increased substantially the number of VLCAD cases, even though the diagnosis needs to be confirmed by ACADVL genetic analysis and/or functional studies on fibroblasts or lymphocytes. Here, ACADVL is linked to very long chain acyl-CoA dehydrogenase deficiency.